Overview

Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to describe Tamsulosin prescription characteristics in a representative population of patients on treatment for benign prostatic hyperplasia
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Tamsulosin